NEW YORK – Adaptive Biotechnologies reported a 1 percent year-over-year increase in third quarter revenues after the close of the market on Tuesday.
For the three months ended Sept. 30, Adaptive reported $26.3 million in revenues, up from $26.1 million during the year-ago period and beating the consensus Wall Street estimate of $23.6 million.